TRUNCATED VARICELLA-ZOSTER VIRUS ENVELOPE GLYCOPROTEIN GE

NUCLEIC ACID VACCINES FOR VARICELLA ZOSTER VIRUS (VZV)

IMMUNOGENICITY OF A CPG-ADJUVANTED HERPES ZOSTER VACCINE

VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE

Genetically Modified Bovine Herpesvirus Type 1 (BHV-1) for use to Treat Cancer

DRY LIPOSOME ADJUVANT-CONTAINING VACCINES AND RELATED METHODS THEREOF

Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex

Antigen variant of Varicella Zoster virus and use thereof

VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE

Vaccine compositions of herpesvirus envelope protein combinations to induce immune response

Varicella zoster virus vaccine

Cationic oil-in-water emulsions

Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex

Immunostimulatory plasmids

Liposomal adjuvant compositions

Cationic oil-in-water emulsions

Vaccine compositions comprising a saponin adjuvant

Gene-deleted variant strain of porcine pseudorabies virus, vaccine composition, method of making the same and use thereof

Gene-deleted variant strain of porcine pseudorabies virus, vaccine composition, method of making the same and use thereof

Porcine pseudorabies virus, vaccine composition and preparation method and use thereof

Immunostimulatory plasmids

Bovine herpes virus vaccine with multiple mutations

Vaccine compositions comprising a saponin adjuvant

Vaccine Compositions Comprising a Saponin Adjuvant

Nucleic acid-based adjuvant and porcine vaccine composition including the same

Nucleic acid vaccines for varicella zoster virus (VZV)